FSB Premier Wealth Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-332
Closed -$20K – 390
2021
Q4
$20K Buy
+332
New +$25.2K 0.01% 348

Other funds holding OPRX

FSB Premier Wealth Management's OPRX Position: Q1 2022 in Review

FSB Premier Wealth Management sold out of OptimizeRx (OPRX) in Q1 2022, closing a stake of 332 shares — an estimated $20K sold.

FSB Premier Wealth Management first reported a position in OPRX in Q4 2021 and held it in 1 quarter. The position peaked at $20K in Q4 2021. 153 funds tracked by Wall St. Rank hold OPRX as of Q1 2022.

  • FSB Premier Wealth Management reported no remaining OptimizeRx position as of Q1 2022 after selling out during the quarter.
  • FSB Premier Wealth Management sold 332 OptimizeRx shares in Q1 2022, an estimated $20K.
  • FSB Premier Wealth Management first reported a position in OptimizeRx in Q4 2021 and held it in 1 quarter.
  • FSB Premier Wealth Management's OptimizeRx position peaked at $20K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2022.

Based on FSB Premier Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.